The dosage of the catalytic material is a critical factor in determining the extent of the immune response. Lower doses might not elicit a significant immune reaction, whereas higher doses can lead to substantial immune activation. Therefore, it is essential to optimize the amount of catalyst used to minimize potential adverse effects while maintaining catalytic efficiency.
